'We are lowering our prices' in the U.S. says Novo Nordisk CFO

Karsten Munk Knudsen, CFO of Novo Nordisk, discusses the prospect of tariffs on pharmaceuticals and the importance of the U.S. market to the Danish drugmaker.

mercoledì 6 agosto 2025 New tab

26 words~1 min read

Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SG

Get this delivered to your inbox, and more info about our products and services.

Other newsrooms on this story

· 3 sources

Full timeline →

theguardian.com·Aug 6, 2025 · 9 mesi fa
Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply
faz.net·Aug 1, 2025 · 9 mesi fa
Novo Nordisk: Neuer Chef Doustdar soll Kurssturz stoppen
ft.com·Aug 6, 2025 · 9 mesi fa
Novo Nordisk calls for US import ban on key ingredient for obesity drug copycats

Other newsrooms on this story

· 3 sources

Full timeline →

Related reading

cnbc.com

Novo Nordisk CEO addresses U.S. headwinds after guidance shock

Novo Nordisk CEO Mike Doustdar discusses the pharma giant's Q4 reporting, uptake of obesity drugs and how he plans to navigate…

cnbc.com3 mesi fa

cnbc.com

UBS downgrades Novo Nordisk, cites 'rapidly deteriorating growth' in GLP-1…

Novo Nordisk is losing market share despite its having a "comprehensive portfolio" compared to peers, the firm said.

cnbc.com9 mesi fa

cnbc.com

Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets…

Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise prereleased its 2026…

cnbc.com3 mesi fa

cnbc.com

Novo Nordisk job cuts a necessary reset after hypergrowth, analysts say

The Wegovy obesity drug maker on Wednesday announced plans to trim 11.5% of its workforce.

cnbc.com8 mesi fa

cnbc.com

TD Cowen downgrades Novo Nordisk on concerns over semaglutide patent loss,…

TD Cowen still sees shares of Novo Nordisk adding 6% from here.

cnbc.com2 mesi fa

cnbc.com

Novo Nordisk CEO: Aim is to expand weight-loss market in U.S.

Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the…

cnbc.com8 g fa